News

FDA approves Moderna's new lower-dose COVID-19 vaccine
The Food and Drug administration has approved a new COVID-19 vaccine made by Moderna but with limits on who can use it.
Beam Therapeutics Announces U.S. FDA Orphan Drug Designation Granted to BEAM-302 for the Treatment of Alpha-1 Antitrypsin Deficiency (AATD)
Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, ...
FDA chief says pregnant women should decide on Covid vaccine with doctors
Health Secretary Robert F. Kennedy Jr.’s decision to revoke the Covid vaccine recommendation for pregnant women has raised ...
What the FDA’s new Covid vaccine policy is really about
It began in 2020 with a coordinated push to generate public backlash to lockdowns. The ultimate aim was restoring normalcy, ...
Rates of liver injuries rise in the U.S. as supplements grow in popularity
The liver is responsible for more than 500 functions in the human body, including filtering harmful substances from the blood ...
Silence on E. Coli Outbreak Highlights How Trump Team's Changes Undermine Food Safety
FDA's silence on E. coli outbreak linked to lettuce raises concerns about food safety oversight. Trump administration's ...
The Manhattan Mercury2d
U.S. Ends $600M Moderna Bird Flu Vaccine Contract
THURSDAY, May 29, 2025 (HealthDay News) — The U.S. government has canceled a $600 million contract with Moderna to develop a ...
FDA panel is split on updates to COVID shots as questions loom for fall vaccinations
Government vaccine advisers are meeting to decide if the recipe for COVID-19 vaccines needs updating for this fall and winter ...
Food Safety News4d
FDA warns seafood processors in Venezuela and South Korea about botulism risks
As part of its enforcement activities, the Food and Drug Administration sends warning letters to entities under its ...
Opinion
The FDA’s misguided new Covid vaccine policy repeats past mistakes
Its new guidance would trade the clarity and reach of our current strategy for a confusing framework that simply doesn’t fit reality.
Longview News-Journal12d
U.S. FDA Approves BLA for Novavax's COVID-19 Vaccine
Novavax expects to be ready for the commercial delivery of the 2025-2026 COVID-19 vaccine formula in the U.S. this fall in partnership with Sanofi, pending strain recommendation at the FDA ...